BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 12207332)

  • 21. PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
    Torlakovic E; Malecka A; Myklebust JH; Tierens A; Aasheim HC; Nesland JM; Smeland E; Kvaløy S; Delabie J
    J Pathol; 2005 Jul; 206(3):312-9. PubMed ID: 15892171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity.
    Jellusova J; Wellmann U; Amann K; Winkler TH; Nitschke L
    J Immunol; 2010 Apr; 184(7):3618-27. PubMed ID: 20200274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Ets factor Spi-B is a direct critical target of the coactivator OBF-1.
    Bartholdy B; Du Roure C; Bordon A; Emslie D; Corcoran LM; Matthias P
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11665-70. PubMed ID: 16861304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular interactions regulate BCR signal inhibition by CD22 and CD72.
    Nitschke L; Tsubata T
    Trends Immunol; 2004 Oct; 25(10):543-50. PubMed ID: 15364057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD22 as a target of passive immunotherapy.
    Cesano A; Gayko U
    Semin Oncol; 2003 Apr; 30(2):253-7. PubMed ID: 12720147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SLP-76 is recruited to CD22 and dephosphorylated by SHP-1, thereby regulating B cell receptor-induced c-Jun N-terminal kinase activation.
    Mizuno K; Tagawa Y; Watanabe N; Ogimoto M; Yakura H
    Eur J Immunol; 2005 Feb; 35(2):644-54. PubMed ID: 15668918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BOB.1/OBF.1 is required during B-cell ontogeny for B-cell differentiation and germinal center function.
    Betzler AC; Fiedler K; Hoffmann TK; Fehling HJ; Wirth T; Brunner C
    Eur J Immunol; 2022 Mar; 52(3):404-417. PubMed ID: 34918350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myosin light chain 1 atrial isoform (MLC1A) is expressed in pre-B cells under control of the BOB.1/OBF.1 coactivator.
    Laumen H; Brunner C; Greiner A; Wirth T
    Nucleic Acids Res; 2004; 32(4):1577-83. PubMed ID: 15004244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The OBF-1 gene locus confers B cell-specific transcription by restricting the ubiquitous activity of its promoter.
    Massa S; Junker S; Schubart K; Matthias G; Matthias P
    Eur J Immunol; 2003 Oct; 33(10):2864-74. PubMed ID: 14515270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils, and monocytes.
    Engel P; Nojima Y; Rothstein D; Zhou LJ; Wilson GL; Kehrl JH; Tedder TF
    J Immunol; 1993 Jun; 150(11):4719-32. PubMed ID: 7684411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD22 forms a quaternary complex with SHIP, Grb2, and Shc. A pathway for regulation of B lymphocyte antigen receptor-induced calcium flux.
    Poe JC; Fujimoto M; Jansen PJ; Miller AS; Tedder TF
    J Biol Chem; 2000 Jun; 275(23):17420-7. PubMed ID: 10748054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Origins of peripheral B cells in IL-7 receptor-deficient mice.
    Hesslein DG; Yang SY; Schatz DG
    Mol Immunol; 2006 Feb; 43(4):326-34. PubMed ID: 16310046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice.
    Rickert RC; Rajewsky K; Roes J
    Nature; 1995 Jul; 376(6538):352-5. PubMed ID: 7543183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expansion of CD22lo B cells in the spleen of autoimmune-prone flaky skin mice.
    Mattsson N; Duzevik EG; Pelsue SC
    Cell Immunol; 2005 Apr; 234(2):124-32. PubMed ID: 16054613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors.
    Horikawa K; Martin SW; Pogue SL; Silver K; Peng K; Takatsu K; Goodnow CC
    J Exp Med; 2007 Apr; 204(4):759-69. PubMed ID: 17420266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Lyn/CD22 double-deficient B cells in vivo demonstrates Lyn- and CD22-independent pathways affecting BCR regulation and B cell survival.
    Ferry H; Crockford TL; Silver K; Rust N; Goodnow CC; Cornall RJ
    Eur J Immunol; 2005 Dec; 35(12):3655-63. PubMed ID: 16278813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the expression and gene promoter of CD22 in murine B cells.
    Andersson KB; Draves KE; Magaletti DM; Fujioka S; Holmes KL; Law CL; Clark EA
    Eur J Immunol; 1996 Dec; 26(12):3170-8. PubMed ID: 8977319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ig domains 1 and 2 of murine CD22 constitute the ligand-binding domain and bind multiple sialylated ligands expressed on B and T cells.
    Law CL; Aruffo A; Chandran KA; Doty RT; Clark EA
    J Immunol; 1995 Oct; 155(7):3368-76. PubMed ID: 7561031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Failure of B-cell differentiation in mice lacking the transcription factor EBF.
    Lin H; Grosschedl R
    Nature; 1995 Jul; 376(6537):263-7. PubMed ID: 7542362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD22 attenuates calcium signaling by potentiating plasma membrane calcium-ATPase activity.
    Chen J; McLean PA; Neel BG; Okunade G; Shull GE; Wortis HH
    Nat Immunol; 2004 Jun; 5(6):651-7. PubMed ID: 15133509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.